Molecular strategies to define HLA haplotype loss in microdissected tumor cells.
Loss of heterozygosity (LOH) of chromosome 6p21 is an important mechanism that generates HLA haplotype loss in various human tumors. This mechanism produces non-reversible HLA-deficient tumor cells that can escape T cell immune responses in peptide-vaccinated cancer patients. However, the exact frequency of this mechanism is still unknown, because contaminating stroma in solid tumor tissues masks the tumor DNA obtained from solid samples. A microdissection technique was applied to 4-8 microm sections of cryopreserved tumor tissues from a group of colorectal and laryngeal carcinomas. Fifteen patients were analyzed for the presence of LOH associated with the beta(2)-microglobulin gene in chromosome 15, and five patients for LOH associated with HLA genes in chromosome 6. In two cases, autologous metastasis tissue samples were also available. The patients were selected for showing an altered HLA class I tumor phenotype as determined by immunohistological techniques. DNA was obtained from this microdissected material and amplified in order to detect the presence or absence of nine previously selected microsatellite markers. HLA sequence based typing (SBT) was also applied to these microdissected DNA samples to define the HLA genotype. Microdissection greatly improved the definition of LOH, with nearly 100% signal reduction in one of the alleles. In addition, this procedure allowed us to detect beta(2)-microglobulin LOH in tumors that expressed some HLA molecules. Our data indicate that this procedure can be successfully applied to microdissected samples from solid tumors, thus enhancing the power and sensitivity of LOH detection.
Ramal
L M
LM
Department of Analisis Clinicos, Granada, Spain.
Maleno
I
I
Cabrera
T
T
Collado
A
A
Ferron
A
A
Lopez-Nevot
M A
MA
Garrido
F
F
D015179:Colorectal Neoplasms / Q000235:genetics* / Q000276:immunology; D015925:Cryopreservation; D006680:HLA Antigens / Q000145:classification / Q000235:genetics* / Q000378:metabolism; D006239:Haplotypes; D006650:Histocompatibility Testing; D006652:Histological Techniques; D006801:Humans; D007822:Laryngeal Neoplasms / Q000235:genetics* / Q000276:immunology; D019656:Loss of Heterozygosity / Q000235:genetics*; D008214:Lymphocytes / Q000145:classification / Q000276:immunology; D018895:Microsatellite Repeats / Q000235:genetics*; D010641:Phenotype; D001613:beta 2-Microglobulin / Q000378:metabolism
D006680:HLA Antigens; D001613:beta 2-Microglobulin